Enigma of COVID-19: is “multisystem inflammatory syndrome in adults” (MIS-A) predictable?

4Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Severe inflammation and one or more extrapulmonary organ dysfunctions have been reported and this clinical picture is defined as "multisystem inflammatory syndrome in adults" (MIS-A) in severe coronavirus disease-2019 (COVID-19). We aimed to determine the effect of LDH/lymphocyte ratio (LLR) on the development of MIS-A. Methods: The data of 2333 patients were retrospectively analyzed. Results: MIS-A rate was found to be 9.9% and MIS-A related mortality was 35.3%. LRR level above 0.24 was found to predict MIS-A development with 70% sensitivity and 65.2% specificity. The risk of MIS-A development was found to be 3.64 times higher in those with LRR levels above 0.24 compared to those with 0.24 and below. In patients with MIS-A, LRR level above 0.32 predicts mortality with 78% sensitivity and 70% specificity. Conclusions: Early detection of MIS-A with high sensitivity and specificity in a practical ratio is very important in terms new studies.

Cite

CITATION STYLE

APA

Serin, I., Sari, N. D., Gunaltili, M., Karakilic, A., Gulesir, B., Kal Kolik, B., … Cinli, T. A. (2022). Enigma of COVID-19: is “multisystem inflammatory syndrome in adults” (MIS-A) predictable? BMC Infectious Diseases, 22(1). https://doi.org/10.1186/s12879-022-07303-8

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free